{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:26:35Z","timestamp":1794108395871,"version":"4.8.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014392","name":"Avid Radiopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rodin Therapeutics"},{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mechanism of synaptic loss in Alzheimer\u2019s disease is poorly understood and may be associated with tau pathology. In this combined positron emission tomography (PET) and magnetoencephalography (MEG) study, we aimed to investigate spatial associations between regional tau pathology ([<jats:sup>18<\/jats:sup>F]flortaucipir PET), synaptic density (synaptic vesicle 2A [<jats:sup>11<\/jats:sup>C]UCB-J PET) and synaptic function (MEG) in Alzheimer\u2019s disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seven amyloid-positive Alzheimer\u2019s disease subjects from the Amsterdam Dementia Cohort underwent dynamic 130-min [<jats:sup>18<\/jats:sup>F]flortaucipir PET, dynamic 60-min [<jats:sup>11<\/jats:sup>C]UCB-J PET with arterial sampling and 2\u2009\u00d7\u20095-min resting-state MEG measurement. [<jats:sup>18<\/jats:sup>F]flortaucipir- and [<jats:sup>11<\/jats:sup>C]UCB-J-specific binding (binding potential, BP<jats:sub>ND<\/jats:sub>) and MEG spectral measures (relative delta, theta and alpha power; broadband power; and peak frequency) were assessed in cortical brain regions of interest. Associations between regional [<jats:sup>18<\/jats:sup>F]flortaucipir\u00a0BP<jats:sub>ND<\/jats:sub>, [<jats:sup>11<\/jats:sup>C]UCB-J BP<jats:sub>ND<\/jats:sub> and MEG spectral measures were assessed using Spearman correlations and generalized estimating equation models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Across subjects, higher regional [<jats:sup>18<\/jats:sup>F]flortaucipir uptake was associated with lower [<jats:sup>11<\/jats:sup>C]UCB-J uptake. Within subjects, the association between [<jats:sup>11<\/jats:sup>C]UCB-J and [<jats:sup>18<\/jats:sup>F]flortaucipir depended on within-subject neocortical tau load; negative associations were observed when neocortical tau load was high, gradually changing into opposite patterns with decreasing neocortical tau burden. Both higher [<jats:sup>18<\/jats:sup>F]flortaucipir and lower [<jats:sup>11<\/jats:sup>C]UCB-J uptake were associated with altered synaptic function, indicative of slowing of oscillatory activity, most pronounced in the occipital lobe.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results indicate that in Alzheimer\u2019s disease, tau pathology is closely associated with reduced synaptic density and synaptic dysfunction.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-021-00772-0","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T04:28:35Z","timestamp":1612758515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["In vivo tau pathology is associated with synaptic loss and altered synaptic function"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-9101","authenticated-orcid":false,"given":"Emma M.","family":"Coomans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah N.","family":"Schoonhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayel","family":"Tuncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander C. J.","family":"Verfaillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"den Braber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiep","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep S. V.","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Hillebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida A.","family":"Gouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N. M.","family":"van Berckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"issue":"10043","key":"772_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer\u2019s disease. Lancet. 2016;388(10043):505\u201317.","journal-title":"Lancet."},{"issue":"5","key":"772_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol. 1990;27(5):457\u201364.","journal-title":"Ann Neurol"},{"issue":"4","key":"772_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572\u201380.","journal-title":"Ann Neurol"},{"issue":"12","key":"772_CR4","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140(12):3286\u2013300.","journal-title":"Brain."},{"issue":"Pt 5","key":"772_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139(Pt 5):1551\u201367.","journal-title":"Brain."},{"issue":"6","key":"772_CR6","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1212\/WNL.0000000000006875","volume":"92","author":"R Ossenkoppele","year":"2019","unstructured":"Ossenkoppele R, Smith R, Ohlsson T, Strandberg O, Mattsson N, Insel PS, et al. Associations between tau, Abeta, and cortical thickness with cognition in Alzheimer disease. Neurology. 2019;92(6):e601\u2013e12.","journal-title":"Neurology."},{"issue":"5","key":"772_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, et al. PET imaging of tau deposition in the aging human brain. Neuron. 2016;89(5):971\u201382.","journal-title":"Neuron."},{"issue":"6","key":"772_CR8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2353\/ajpath.2008.070829","volume":"172","author":"JA Fein","year":"2008","unstructured":"Fein JA, Sokolow S, Miller CA, Vinters HV, Yang F, Cole GM, et al. Co-localization of amyloid beta and tau pathology in Alzheimer\u2019s disease synaptosomes. Am J Pathol. 2008;172(6):1683\u201392.","journal-title":"Am J Pathol"},{"issue":"6","key":"772_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1750-3639.2012.00598.x","volume":"22","author":"KM Henkins","year":"2012","unstructured":"Henkins KM, Sokolow S, Miller CA, Vinters HV, Poon WW, Cornwell LB, et al. Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer\u2019s cortical synapses. Brain Pathol. 2012;22(6):826\u201333.","journal-title":"Brain Pathol"},{"issue":"3","key":"772_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/jnc.12991","volume":"133","author":"S Sokolow","year":"2015","unstructured":"Sokolow S, Henkins KM, Bilousova T, Gonzalez B, Vinters HV, Miller CA, et al. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer\u2019s disease. J Neurochem. 2015;133(3):368\u201379.","journal-title":"J Neurochem"},{"issue":"3","key":"772_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00005072-199903000-00007","volume":"58","author":"LM Callahan","year":"1999","unstructured":"Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol. 1999;58(3):275\u201387.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"772_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones TL, Hyman BT. The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease. Neuron. 2014;82(4):756\u201371.","journal-title":"Neuron."},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener. 2011;6:39.","journal-title":"Mol Neurodegener"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"15295","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, McInnes J, Wierda K, Holt M, Herrmann AG, Jackson RJ, et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun. 2017;8:15295.","journal-title":"Nat Commun"},{"issue":"348","key":"772_CR15","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8(348):348ra96.","journal-title":"Sci Transl Med"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2019.02.001","volume":"97","author":"K Heurling","year":"2019","unstructured":"Heurling K, Ashton NJ, Leuzy A, Zimmer ER, Blennow K, Zetterberg H, et al. Synaptic vesicle protein 2A as a potential biomarker in synaptopathies. Mol Cell Neurosci. 2019;97:34\u201342.","journal-title":"Mol Cell Neurosci"},{"issue":"10","key":"772_CR17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","volume":"75","author":"MK Chen","year":"2018","unstructured":"Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, et al. Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA Neurol. 2018;75(10):1215\u201324.","journal-title":"JAMA Neurol"},{"key":"772_CR18","doi-asserted-by":"crossref","unstructured":"Bastin C, Bahri MA, Meyer F, Manard M, Delhaye E, Plenevaux A, et al. In vivo imaging of synaptic loss in Alzheimer\u2019s disease with [18F]UCB-H positron emission tomography. Eur J Nucl Med Mol Imaging. 2020;47:390\u2013402.","DOI":"10.1007\/s00259-019-04461-x"},{"issue":"7","key":"772_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/alz.12097","volume":"16","author":"AP Mecca","year":"2020","unstructured":"Mecca AP, Chen MK, O'Dell RS, Naganawa M, Toyonaga T, Godek TA, et al. In vivo measurement of widespread synaptic loss in Alzheimer\u2019s disease with SV2A PET. Alzheimers Dement. 2020;16(7):974\u201382.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"772_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"772_CR21","doi-asserted-by":"crossref","unstructured":"Vanhaute H, Ceccarini J, Michiels L, Koole M, Sunaert S, Lemmens R, et al. In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment. Neurology. 2020;95:e545\u2013e553.","DOI":"10.1212\/WNL.0000000000009818"},{"issue":"5","key":"772_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.neuron.2013.10.017","volume":"80","author":"FL da Silva","year":"2013","unstructured":"da Silva FL. EEG and MEG: relevance to neuroscience. Neuron. 2013;80(5):1112\u201328.","journal-title":"Neuron."},{"issue":"8","key":"772_CR23","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.clinph.2018.03.042","volume":"129","author":"R Hari","year":"2018","unstructured":"Hari R, Baillet S, Barnes G, Burgess R, Forss N, Gross J, et al. IFCN-endorsed practical guidelines for clinical magnetoencephalography (MEG). Clin Neurophysiol. 2018;129(8):1720\u201347.","journal-title":"Clin Neurophysiol"},{"key":"772_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.06.078","volume":"158","author":"R Gao","year":"2017","unstructured":"Gao R, Peterson EJ, Voytek B. Inferring synaptic excitation\/inhibition balance from field potentials. Neuroimage. 2017;158:70\u20138.","journal-title":"Neuroimage."},{"issue":"4","key":"772_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neuron.2009.04.027","volume":"62","author":"BV Atallah","year":"2009","unstructured":"Atallah BV, Scanziani M. Instantaneous modulation of gamma oscillation frequency by balancing excitation with inhibition. Neuron. 2009;62(4):566\u201377.","journal-title":"Neuron."},{"issue":"8","key":"772_CR26","doi-asserted-by":"publisher","first-page":"e1002582","DOI":"10.1371\/journal.pcbi.1002582","volume":"8","author":"W de Haan","year":"2012","unstructured":"de Haan W, Mott K, van Straaten EC, Scheltens P, Stam CJ. Activity dependent degeneration explains hub vulnerability in Alzheimer\u2019s disease. Plos Comput Biol. 2012;8(8):e1002582.","journal-title":"Plos Comput Biol"},{"issue":"8","key":"772_CR27","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.clinph.2017.05.012","volume":"128","author":"MMA Engels","year":"2017","unstructured":"Engels MMA, van der Flier WM, Stam CJ, Hillebrand A, Scheltens P, van Straaten ECW. Alzheimer\u2019s disease: the state of the art in resting-state magnetoencephalography. Clin Neurophysiol. 2017;128(8):1426\u201337.","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"772_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"772_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3233\/JAD-170850","volume":"62","author":"WM van der Flier","year":"2018","unstructured":"van der Flier WM, Scheltens P. Amsterdam dementia cohort: performing research to optimize care. J Alzheimers Dis. 2018;62(3):1091\u2013111.","journal-title":"J Alzheimers Dis"},{"issue":"0","key":"772_CR30","doi-asserted-by":"crossref","first-page":"0271678X2096424","DOI":"10.1177\/0271678X20964248","volume":"0","author":"H Tuncel","year":"2020","unstructured":"Tuncel H, Boellaard R, Coomans EM, de Vries EF, Glaudemans AW, Feltes PK, et al. Kinetics and 28-day test\u2013retest repeatability and reproducibility of [11C]UCB-J PET brain imaging. J Cereb Blood Flow Metab. 2020;0(0):0271678X20964248.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"772_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s11307-017-1080-z","volume":"19","author":"SSV Golla","year":"2017","unstructured":"Golla SSV, Timmers T, Ossenkoppele R, Groot C, Verfaillie S, Scheltens P, et al. Quantification of tau load using [(18) F]AV1451 PET. Mol Imaging Biol. 2017;19(6):963\u201371.","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"772_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19(4):224\u201347.","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"772_CR33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neuroimage.2004.10.017","volume":"24","author":"C Svarer","year":"2005","unstructured":"Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbol S, Frokjaer VG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005;24(4):969\u201379.","journal-title":"Neuroimage."},{"issue":"2","key":"772_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00259-018-4119-8","volume":"46","author":"M Koole","year":"2019","unstructured":"Koole M, van Aalst J, Devrome M, Mertens N, Serdons K, Lacroix B, et al. Quantifying SV2A density and drug occupancy in the human brain using [(11) C]UCB-J PET imaging and subcortical white matter as reference tissue. Eur J Nucl Med Mol Imaging. 2019;46(2):396\u2013406.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"772_CR35","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1177\/0271678X17724947","volume":"38","author":"SJ Finnema","year":"2018","unstructured":"Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, et al. Kinetic evaluation and test-retest reproducibility of [(11) C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans. J Cereb Blood Flow Metab. 2018;38(11):2041\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"key":"772_CR36","doi-asserted-by":"crossref","unstructured":"Golla SS, Wolters EE, Timmers T, Ossenkoppele R, van der Weijden CW, Scheltens P, et al. Parametric methods for [(18) F] flortaucipir PET. J Cereb Blood Flow Metab. 2018;40:271678X18820765.","DOI":"10.1177\/0271678X18820765"},{"issue":"1","key":"772_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13550-017-0284-1","volume":"7","author":"SSV Golla","year":"2017","unstructured":"Golla SSV, Lubberink M, van Berckel BNM, Lammertsma AA, Boellaard R. Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising. EJNMMI Res. 2017;7(1):36.","journal-title":"EJNMMI Res"},{"issue":"7","key":"772_CR38","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1088\/0031-9155\/51\/7\/008","volume":"51","author":"S Taulu","year":"2006","unstructured":"Taulu S, Simola J. Spatiotemporal signal space separation method for rejecting nearby interference in MEG measurements. Phys Med Biol. 2006;51(7):1759\u201368.","journal-title":"Phys Med Biol"},{"issue":"1","key":"772_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clinph.2012.06.013","volume":"124","author":"A Hillebrand","year":"2013","unstructured":"Hillebrand A, Fazio P, de Munck JC, van Dijk BW. Feasibility of clinical magnetoencephalography (MEG) functional mapping in the presence of dental artefacts. Clin Neurophysiol. 2013;124(1):107\u201313.","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"772_CR40","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1016\/j.neuroimage.2011.11.005","volume":"59","author":"A Hillebrand","year":"2012","unstructured":"Hillebrand A, Barnes GR, Bosboom JL, Berendse HW, Stam CJ. Frequency-dependent functional connectivity within resting-state networks: an atlas-based MEG beamformer solution. Neuroimage. 2012;59(4):3909\u201321.","journal-title":"Neuroimage."},{"issue":"14","key":"772_CR41","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1073\/pnas.1515657113","volume":"113","author":"A Hillebrand","year":"2016","unstructured":"Hillebrand A, Tewarie P, van Dellen E, Yu M, Carbo EW, Douw L, et al. Direction of information flow in large-scale resting-state networks is frequency-dependent. Proc Natl Acad Sci U S A. 2016;113(14):3867\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"772_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0074-7742(05)68006-3","volume":"68","author":"A Hillebrand","year":"2005","unstructured":"Hillebrand A, Barnes GR. Beamformer analysis of MEG data. Int Rev Neurobiol. 2005;68:149\u201371.","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"772_CR43","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1109\/TBME.2004.827926","volume":"51","author":"K Sekihara","year":"2004","unstructured":"Sekihara K, Nagarajan SS, Poeppel D, Marantz A. Asymptotic SNR of scalar and vector minimum-variance beamformers for neuromagnetic source reconstruction. IEEE Trans Biomed Eng. 2004;51(10):1726\u201334.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"8","key":"772_CR44","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.clinph.2007.05.064","volume":"118","author":"D Cheyne","year":"2007","unstructured":"Cheyne D, Bostan AC, Gaetz W, Pang EW. Event-related beamforming: a robust method for presurgical functional mapping using MEG. Clin Neurophysiol. 2007;118(8):1691\u2013704.","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"772_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ana.24321","volume":"77","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, et al. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Ann Neurol. 2015;77(2):338\u201342.","journal-title":"Ann Neurol"},{"issue":"2","key":"772_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol. 2016;80(2):247\u201358.","journal-title":"Ann Neurol"},{"key":"772_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neurobiolaging.2017.05.017","volume":"57","author":"AA Gouw","year":"2017","unstructured":"Gouw AA, Alsema AM, Tijms BM, Borta A, Scheltens P, Stam CJ, et al. EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects. Neurobiol Aging. 2017;57:133\u201342.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"772_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bandc.2009.10.003","volume":"72","author":"SJ Segalowitz","year":"2010","unstructured":"Segalowitz SJ, Santesso DL, Jetha MK. Electrophysiological changes during adolescence: a review. Brain Cogn. 2010;72(1):86\u2013100.","journal-title":"Brain Cogn"},{"key":"772_CR49","doi-asserted-by":"crossref","unstructured":"Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, et al. Neurophysiological signatures in Alzheimer\u2019s disease are distinctly associated with TAU, amyloid-beta accumulation, and cognitive decline. Sci Transl Med. 2020;12(534):eaaz4069.","DOI":"10.1126\/scitranslmed.aaz4069"},{"issue":"1","key":"772_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A","volume":"48","author":"SD Ginsberg","year":"2000","unstructured":"Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ. Expression profile of transcripts in Alzheimer\u2019s disease tangle-bearing CA1 neurons. Ann Neurol. 2000;48(1):77\u201387.","journal-title":"Ann Neurol"},{"issue":"4","key":"772_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"772_CR52","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.clinph.2004.01.001","volume":"115","author":"J Jeong","year":"2004","unstructured":"Jeong J. EEG dynamics in patients with Alzheimer\u2019s disease. Clin Neurophysiol. 2004;115(7):1490\u2013505.","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"772_CR53","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/hbm.24470","volume":"40","author":"PP Shah-Basak","year":"2019","unstructured":"Shah-Basak PP, Kielar A, Deschamps T, Verhoeff NP, Jokel R, Meltzer J. Spontaneous oscillatory markers of cognitive status in two forms of dementia. Hum Brain Mapp. 2019;40(5):1594\u2013607.","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"772_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron. 2007;55(5):697\u2013711.","journal-title":"Neuron."},{"issue":"1","key":"772_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12017-009-8097-7","volume":"12","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L. Synaptic depression and aberrant excitatory network activity in Alzheimer\u2019s disease: two faces of the same coin? NeuroMolecular Med. 2010;12(1):48\u201355.","journal-title":"NeuroMolecular Med"},{"issue":"3","key":"772_CR56","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/hbm.20273","volume":"28","author":"TJ Whitford","year":"2007","unstructured":"Whitford TJ, Rennie CJ, Grieve SM, Clark CR, Gordon E, Williams LM. Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology. Hum Brain Mapp. 2007;28(3):228\u201337.","journal-title":"Hum Brain Mapp"},{"key":"772_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fnhum.2016.00238","volume":"10","author":"MM Engels","year":"2016","unstructured":"Engels MM, Hillebrand A, van der Flier WM, Stam CJ, Scheltens P, van Straaten EC. Slowing of hippocampal activity correlates with cognitive decline in early onset Alzheimer\u2019s disease. An MEG Study with Virtual Electrodes. Front Hum Neurosci. 2016;10:238.","journal-title":"Front Hum Neurosci"},{"issue":"16","key":"772_CR58","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1523\/JNEUROSCI.3263-16.2017","volume":"37","author":"AP Schultz","year":"2017","unstructured":"Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, et al. Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals. J Neurosci. 2017;37(16):4323\u201331.","journal-title":"J Neurosci"},{"issue":"2","key":"772_CR59","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, et al. Trans-synaptic spread of tau pathology in vivo. Plos One. 2012;7(2):e31302.","journal-title":"Plos One"},{"issue":"4","key":"772_CR60","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler AM, Phillips EC, Lau DH, Noble W, Hanger DP. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 2013;14(4):389\u201394.","journal-title":"EMBO Rep"},{"issue":"8","key":"772_CR61","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K, et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci. 2016;19(8):1085\u201392.","journal-title":"Nat Neurosci"},{"issue":"3","key":"772_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, et al. Neuronal activity regulates extracellular tau in vivo. J Exp Med. 2014;211(3):387\u201393.","journal-title":"J Exp Med"},{"issue":"5","key":"772_CR63","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.neuron.2015.01.025","volume":"85","author":"N Menkes-Caspi","year":"2015","unstructured":"Menkes-Caspi N, Yamin HG, Kellner V, Spires-Jones TL, Cohen D, Stern EA. Pathological tau disrupts ongoing network activity. Neuron. 2015;85(5):959\u201366.","journal-title":"Neuron."},{"issue":"6","key":"772_CR64","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-015-1413-4","volume":"129","author":"IC Stancu","year":"2015","unstructured":"Stancu IC, Vasconcelos B, Ris L, Wang P, Villers A, Peeraer E, et al. Templated misfolding of tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice. Acta Neuropathol. 2015;129(6):875\u201394.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"772_CR65","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1523\/JNEUROSCI.1397-18.2018","volume":"39","author":"W Huijbers","year":"2019","unstructured":"Huijbers W, Schultz AP, Papp KV, LaPoint MR, Hanseeuw B, Chhatwal JP, et al. Tau accumulation in clinically normal older adults is associated with hippocampal hyperactivity. J Neurosci. 2019;39(3):548\u201356.","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"772_CR66","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.neurobiolaging.2011.09.009","volume":"32","author":"R Sperling","year":"2011","unstructured":"Sperling R. Potential of functional MRI as a biomarker in early Alzheimer\u2019s disease. Neurobiol Aging. 2011;32(Suppl 1):S37\u201343.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"772_CR67","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.clinph.2009.03.004","volume":"120","author":"JL Bosboom","year":"2009","unstructured":"Bosboom JL, Stoffers D, Stam CJ, Berendse HW, Wolters E. Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson\u2019s disease related dementia. Clin Neurophysiol. 2009;120(5):910\u20135.","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"772_CR68","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.clinph.2012.09.017","volume":"124","author":"C Babiloni","year":"2013","unstructured":"Babiloni C, Del Percio C, Bordet R, Bourriez JL, Bentivoglio M, Payoux P, et al. Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer\u2019s disease patients. Clin Neurophysiol. 2013;124(5):837\u201350.","journal-title":"Clin Neurophysiol"},{"issue":"7","key":"772_CR69","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/brain.2019.0662","volume":"9","author":"J Marquetand","year":"2019","unstructured":"Marquetand J, Vannoni S, Carboni M, Li Hegner Y, Stier C, Braun C, et al. Reliability of magnetoencephalography and high-density electroencephalography resting-state functional connectivity metrics. Brain Connect. 2019;9(7):539\u201353.","journal-title":"Brain Connect"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-021-00772-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T04:31:47Z","timestamp":1612758707000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00772-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00772-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The BEBO Foundation Medical Ethics Committee (Assen, The Netherlands) and the local Institutional Review Board of the VUmc (Amsterdam, The Netherlands) approved the study. All subjects provided written informed consent prior to the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"E.C., D.S., H.T., S.V., E.W., R.B., R.O., A.B., W.S., P.S., R.S., A.W., F.B., Ph.S., S.G., A.H., A.G. and B.B. declare that they have no conflict of interest.S.S. and J.M.R. are employees of Rodin Therapeutics Inc.; they contributed to the implementation and writing of this study, but did not contribute to the design and analysis of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}